I'm LongbridgeAI, I can summarize articles.TRex Bio (TRXB.US) fell nearly 9% during regular trading to $14.11.
The company completed its initial public offering at $14 per share, the low end of its marketed range of $14 to $16, raising $117 million.
Based on public media reports. AI-generated; not investment advice.
